View ValuationZhejiang Runtu 将来の成長Future 基準チェック /16Zhejiang Runtuは、7.3%と9.1%でそれぞれ年率7.3%で利益と収益が成長すると予測される一方、EPSはgrowで5.2%年率。主要情報7.3%収益成長率5.21%EPS成長率Chemicals 収益成長30.6%収益成長率9.1%将来の株主資本利益率n/aアナリストカバレッジLow最終更新日29 Apr 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesBoard Change • May 20Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Jian Wo was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.お知らせ • Apr 29Zhejiang Runtu Co., Ltd., Annual General Meeting, May 29, 2026Zhejiang Runtu Co., Ltd., Annual General Meeting, May 29, 2026, at 14:00 China Standard Time. Location: Building 1, No. 1009, Shimin Avenue, Shangyu District, Shaoxing, Zhejiang Chinaお知らせ • Mar 31Zhejiang Runtu Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026Zhejiang Runtu Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026お知らせ • Dec 31Zhejiang Runtu Co., Ltd. to Report Fiscal Year 2025 Results on Apr 29, 2026Zhejiang Runtu Co., Ltd. announced that they will report fiscal year 2025 results on Apr 29, 2026お知らせ • Sep 30Zhejiang Runtu Co., Ltd. to Report Q3, 2025 Results on Oct 29, 2025Zhejiang Runtu Co., Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025お知らせ • Jul 02Zhejiang Runtu Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025Zhejiang Runtu Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025お知らせ • May 27Zhejiang Runtu Co., Ltd. Approves Dividend for 2024Zhejiang Runtu Co., Ltd. at its AGM held on May 23, 2025 approved Cash dividend/10 shares (tax included): CNY 1.50000000 for 2024.お知らせ • Apr 29Zhejiang Runtu Co., Ltd., Annual General Meeting, May 23, 2025Zhejiang Runtu Co., Ltd., Annual General Meeting, May 23, 2025, at 14:00 China Standard Time.お知らせ • Mar 31Zhejiang Runtu Co., Ltd. to Report Q1, 2025 Results on Apr 29, 2025Zhejiang Runtu Co., Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025お知らせ • Dec 31Zhejiang Runtu Co., Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025Zhejiang Runtu Co., Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.04 (vs CN¥0.035 loss in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.04 (up from CN¥0.035 loss in 3Q 2023). Revenue: CN¥1.38b (up 6.8% from 3Q 2023). Net income: CN¥46.4m (up CN¥88.0m from 3Q 2023). Profit margin: 3.4% (up from net loss in 3Q 2023). Revenue is forecast to grow 4.5% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 69 percentage points per year, which is a significant difference in performance.お知らせ • Sep 30Zhejiang Runtu Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024Zhejiang Runtu Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024Reported Earnings • Aug 31Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: CN¥1.44b (down 8.6% from 2Q 2023). Net income: CN¥103.3m (down 23% from 2Q 2023). Profit margin: 7.2% (down from 8.6% in 2Q 2023). Revenue is forecast to grow 5.0% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 53 percentage points per year, which is a significant difference in performance.お知らせ • Jun 29Zhejiang Runtu Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024Zhejiang Runtu Co., Ltd. announced that they will report first half, 2024 results on Aug 31, 2024Declared Dividend • Jun 21Dividend reduced to CN¥0.15Dividend of CN¥0.15 is 40% lower than last year. Ex-date: 26th June 2024 Payment date: 26th June 2024 Dividend yield will be 2.7%, which is about the same as the industry average. Sustainability & Growth Dividend is not covered by earnings (445% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 1.2% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 395% to bring the payout ratio under control. EPS is expected to grow by 76% over the next year, which means the dividend may need to be reduced to reach a sustainable payout ratio.お知らせ • Jun 20Zhejiang Runtu Co., Ltd. Announces Final Dividend on A Shares for the Year 2023, Payable on 26 June 2024Zhejiang Runtu Co., Ltd. announced final cash dividend/10 shares (tax included) of CNY 1.50000000 on A shares for the year 2023. Record date is 25 June 2024. Ex-date is 26 June 2024. Payment date is 26 June 2024.お知らせ • May 02Zhejiang Runtu Co., Ltd. Proposes Final Cash Dividend for the Year 2023Zhejiang Runtu Co., Ltd. proposed final cash dividend of CNY 1.50000000 per ten shares (tax included) for the year 2023.お知らせ • May 01Zhejiang Runtu Co., Ltd., Annual General Meeting, May 24, 2024Zhejiang Runtu Co., Ltd., Annual General Meeting, May 24, 2024, at 14:00 China Standard Time. Location: Building 1, No. 1009, Shimin Avenue, Shangyu District, Shaoxing, Zhejiang ChinaReported Earnings • Apr 30First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: CN¥1.25b (down 6.9% from 1Q 2023). Net income: CN¥1.31m (down 86% from 1Q 2023). Profit margin: 0.1% (down from 0.7% in 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.お知らせ • Mar 30Zhejiang Runtu Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024Zhejiang Runtu Co., Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024Valuation Update With 7 Day Price Move • Feb 12Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥5.90, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 43% over the past three years.お知らせ • Dec 30Zhejiang Runtu Co., Ltd. to Report Fiscal Year 2023 Results on Apr 30, 2024Zhejiang Runtu Co., Ltd. announced that they will report fiscal year 2023 results on Apr 30, 2024Reported Earnings • Nov 01Third quarter 2023 earnings released: CN¥0.035 loss per share (vs CN¥0.046 profit in 3Q 2022)Third quarter 2023 results: CN¥0.035 loss per share (down from CN¥0.046 profit in 3Q 2022). Revenue: CN¥1.30b (down 10% from 3Q 2022). Net loss: CN¥41.6m (down 182% from profit in 3Q 2022). Revenue is forecast to grow 7.9% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.お知らせ • Sep 30Zhejiang Runtu Co., Ltd. to Report Q3, 2023 Results on Oct 31, 2023Zhejiang Runtu Co., Ltd. announced that they will report Q3, 2023 results on Oct 31, 2023New Risk • Sep 13New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 45% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 111% Paying a dividend despite having no free cash flows. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.3% net profit margin).Reported Earnings • Aug 31Second quarter 2023 earnings released: EPS: CN¥0.10 (vs CN¥0.25 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.10 (down from CN¥0.25 in 2Q 2022). Revenue: CN¥1.57b (down 14% from 2Q 2022). Net income: CN¥134.5m (down 53% from 2Q 2022). Profit margin: 8.6% (down from 16% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 2.3% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.お知らせ • Jun 14Zhejiang Runtu Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 20 June 2023Zhejiang Runtu Co., Ltd. announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 2.50000000 for the year 2022, payable on 20 June 2023. Record date is 19 June 2023. Ex-date is 20 June 2023.お知らせ • Jun 01Zhejiang Runtu Co., Ltd. Approves Dividend for 2022Zhejiang Runtu Co., Ltd. announced at the AGM held on May 26, 2023 that the company approved Cash dividend/10 shares (tax included) of CNY2.50000000 for 2022.お知らせ • May 06+ 1 more updateZhejiang Runtu Co., Ltd., Annual General Meeting, May 26, 2023Zhejiang Runtu Co., Ltd., Annual General Meeting, May 26, 2023, at 14:00 China Standard Time. Agenda: To consider 2022 work report of the board of directors; to consider 2022 work report of the supervisory committee; to consider 2022 annual accounts; to consider 2022 annual report and its summary; to consider 2022 profit distribution plan; to consider Confirmation of 2022 remuneration for directors and supervisors; to consider Reappointment of 2023 audit firm; to consider Provision of guarantee quota for subsidiaries and controlled sub-subsidiaries; and to consider other business matters.Reported Earnings • Apr 08Full year 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.74 in FY 2021)Full year 2022 results: EPS: CN¥0.57 (down from CN¥0.74 in FY 2021). Revenue: CN¥6.30b (up 13% from FY 2021). Net income: CN¥645.2m (down 23% from FY 2021). Profit margin: 10% (down from 15% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 6 non-independent directors. Non-Independent Director Heng Ru was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 31Third quarter 2022 earnings released: EPS: CN¥0.046 (vs CN¥0.24 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.046 (down from CN¥0.24 in 3Q 2021). Revenue: CN¥1.45b (down 3.3% from 3Q 2021). Net income: CN¥50.5m (down 81% from 3Q 2021). Profit margin: 3.5% (down from 18% in 3Q 2021). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.Reported Earnings • Sep 02Second quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.21 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.25 (up from CN¥0.21 in 2Q 2021). Revenue: CN¥1.84b (up 37% from 2Q 2021). Net income: CN¥288.6m (up 29% from 2Q 2021). Profit margin: 16% (down from 17% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 4.0%, compared to a 33% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.Reported Earnings • May 02First quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.15 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.19 (up from CN¥0.15 in 1Q 2021). Revenue: CN¥1.58b (up 12% from 1Q 2021). Net income: CN¥211.1m (up 20% from 1Q 2021). Profit margin: 13% (in line with 1Q 2021). Over the next year, revenue is forecast to grow 18%, compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has fallen by 21% per year whereas the company’s share price has fallen by 18% per year.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 6 non-independent directors. Non-Independent Director Heng Ru was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Apr 01Full year 2021 earnings released: EPS: CN¥0.76 (vs CN¥0.69 in FY 2020)Full year 2021 results: EPS: CN¥0.76 (up from CN¥0.69 in FY 2020). Revenue: CN¥5.60b (up 7.0% from FY 2020). Net income: CN¥863.5m (up 9.6% from FY 2020). Profit margin: 15% (in line with FY 2020). Over the next year, revenue is forecast to grow 19%, compared to a 48% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has fallen by 21% per year whereas the company’s share price has fallen by 20% per year.Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.24 (vs CN¥0.16 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥1.50b (up 7.7% from 3Q 2020). Net income: CN¥268.0m (up 48% from 3Q 2020). Profit margin: 18% (up from 13% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.Reported Earnings • Aug 30Second quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.13 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.34b (up 19% from 2Q 2020). Net income: CN¥224.2m (up 55% from 2Q 2020). Profit margin: 17% (up from 13% in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.Reported Earnings • Apr 30Full year 2020 earnings released: EPS CN¥0.69 (vs CN¥1.19 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥5.23b (down 20% from FY 2019). Net income: CN¥788.2m (down 43% from FY 2019). Profit margin: 15% (down from 21% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 12% per year, which means it is performing significantly worse than earnings.Reported Earnings • Mar 12Full year 2020 earnings released: EPS CN¥0.68 (vs CN¥1.19 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥5.22b (down 20% from FY 2019). Net income: CN¥785.3m (down 43% from FY 2019). Profit margin: 15% (down from 21% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 12% per year, which means it is performing significantly worse than earnings.Analyst Estimate Surprise Post Earnings • Mar 12Revenue misses expectationsRevenue missed analyst estimates by 9.6%. Over the next year, revenue is forecast to grow 35%, compared to a 52% growth forecast for the Chemicals industry in China.Is New 90 Day High Low • Feb 02New 90-day high: CN¥10.98The company is up 18% from its price of CN¥9.29 on 05 November 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥17.48 per share.Is New 90 Day High Low • Nov 23New 90-day high: CN¥10.38The company is up 5.0% from its price of CN¥9.87 on 25 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥16.48 per share.Reported Earnings • Nov 01Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥849.2m, down 38% from the prior year. Total revenue was CN¥5.06b over the last 12 months, down 22% from the prior year.Is New 90 Day High Low • Oct 31New 90-day low: CN¥8.95The company is down 6.0% from its price of CN¥9.56 on 31 July 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥14.96 per share.業績と収益の成長予測XSEC:002440 - アナリストの将来予測と過去の財務データ ( )CNY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20277,273902N/A881112/31/20267,133753N/A13613/31/20266,134805655689N/A12/31/20255,730669600645N/A9/30/20255,7872881,0391,099N/A6/30/20255,713259817883N/A3/31/20255,723260374450N/A12/31/20245,695213460548N/A9/30/20245,44895127188N/A6/30/20245,3607-337-269N/A3/31/20245,49638-193-109N/A12/31/20235,58846-248-127N/A9/30/20235,614158-482-342N/A6/30/20235,765251-271-98N/A3/31/20236,031405130316N/A1/1/20236,268607687883N/A9/30/20226,187717650902N/A6/30/20226,2379359771,243N/A3/31/20225,7368708751,156N/A1/1/20225,572836342594N/A9/30/20215,825900695793N/A6/30/20215,718814761902N/A3/31/20215,5027349851,085N/A12/31/20205,2287881,4281,548N/A9/30/20205,0598491,6781,804N/A6/30/20205,5109181,7301,835N/A3/31/20205,8551,3401,7981,995N/A12/31/20196,5131,370N/A1,840N/A9/30/20196,5211,374N/A2,010N/A6/30/20196,3221,434N/A2,017N/A3/31/20196,6711,267N/A1,462N/A12/31/20186,4641,313N/A1,226N/A9/30/20186,6131,311N/A931N/A6/30/20186,5361,239N/A818N/A3/31/20186,1991,081N/A729N/A12/31/20176,057935N/A607N/A9/30/20175,795860N/A695N/A6/30/20175,189798N/A948N/A3/31/20174,896762N/A1,114N/A12/31/20164,353660N/A1,247N/A9/30/20164,172495N/A1,901N/A6/30/20164,181398N/A1,350N/A3/31/20164,104457N/A1,390N/A12/31/20154,522734N/A1,263N/A9/30/20154,8051,079N/A509N/A6/30/20154,8701,220N/A648N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 002440の予測収益成長率 (年間7.3% ) は 貯蓄率 ( 2.4% ) を上回っています。収益対市場: 002440の収益 ( 7.3% ) CN市場 ( 27.2% ) よりも低い成長が予測されています。高成長収益: 002440の収益は増加すると予測されていますが、大幅には増加しません。収益対市場: 002440の収益 ( 9.1% ) CN市場 ( 16.2% ) よりも低い成長が予測されています。高い収益成長: 002440の収益 ( 9.1% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 002440の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 16:25終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Zhejiang Runtu Co., Ltd. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。10 アナリスト機関Xiling LiChina International Capital Corporation LimitedTao WeiGoldman SachsCheng GongGuosen Securities Co., Ltd.7 その他のアナリストを表示
Board Change • May 20Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Jian Wo was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
お知らせ • Apr 29Zhejiang Runtu Co., Ltd., Annual General Meeting, May 29, 2026Zhejiang Runtu Co., Ltd., Annual General Meeting, May 29, 2026, at 14:00 China Standard Time. Location: Building 1, No. 1009, Shimin Avenue, Shangyu District, Shaoxing, Zhejiang China
お知らせ • Mar 31Zhejiang Runtu Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026Zhejiang Runtu Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026
お知らせ • Dec 31Zhejiang Runtu Co., Ltd. to Report Fiscal Year 2025 Results on Apr 29, 2026Zhejiang Runtu Co., Ltd. announced that they will report fiscal year 2025 results on Apr 29, 2026
お知らせ • Sep 30Zhejiang Runtu Co., Ltd. to Report Q3, 2025 Results on Oct 29, 2025Zhejiang Runtu Co., Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025
お知らせ • Jul 02Zhejiang Runtu Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025Zhejiang Runtu Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025
お知らせ • May 27Zhejiang Runtu Co., Ltd. Approves Dividend for 2024Zhejiang Runtu Co., Ltd. at its AGM held on May 23, 2025 approved Cash dividend/10 shares (tax included): CNY 1.50000000 for 2024.
お知らせ • Apr 29Zhejiang Runtu Co., Ltd., Annual General Meeting, May 23, 2025Zhejiang Runtu Co., Ltd., Annual General Meeting, May 23, 2025, at 14:00 China Standard Time.
お知らせ • Mar 31Zhejiang Runtu Co., Ltd. to Report Q1, 2025 Results on Apr 29, 2025Zhejiang Runtu Co., Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025
お知らせ • Dec 31Zhejiang Runtu Co., Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025Zhejiang Runtu Co., Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025
Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.04 (vs CN¥0.035 loss in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.04 (up from CN¥0.035 loss in 3Q 2023). Revenue: CN¥1.38b (up 6.8% from 3Q 2023). Net income: CN¥46.4m (up CN¥88.0m from 3Q 2023). Profit margin: 3.4% (up from net loss in 3Q 2023). Revenue is forecast to grow 4.5% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 69 percentage points per year, which is a significant difference in performance.
お知らせ • Sep 30Zhejiang Runtu Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024Zhejiang Runtu Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024
Reported Earnings • Aug 31Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: CN¥1.44b (down 8.6% from 2Q 2023). Net income: CN¥103.3m (down 23% from 2Q 2023). Profit margin: 7.2% (down from 8.6% in 2Q 2023). Revenue is forecast to grow 5.0% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 53 percentage points per year, which is a significant difference in performance.
お知らせ • Jun 29Zhejiang Runtu Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024Zhejiang Runtu Co., Ltd. announced that they will report first half, 2024 results on Aug 31, 2024
Declared Dividend • Jun 21Dividend reduced to CN¥0.15Dividend of CN¥0.15 is 40% lower than last year. Ex-date: 26th June 2024 Payment date: 26th June 2024 Dividend yield will be 2.7%, which is about the same as the industry average. Sustainability & Growth Dividend is not covered by earnings (445% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 1.2% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 395% to bring the payout ratio under control. EPS is expected to grow by 76% over the next year, which means the dividend may need to be reduced to reach a sustainable payout ratio.
お知らせ • Jun 20Zhejiang Runtu Co., Ltd. Announces Final Dividend on A Shares for the Year 2023, Payable on 26 June 2024Zhejiang Runtu Co., Ltd. announced final cash dividend/10 shares (tax included) of CNY 1.50000000 on A shares for the year 2023. Record date is 25 June 2024. Ex-date is 26 June 2024. Payment date is 26 June 2024.
お知らせ • May 02Zhejiang Runtu Co., Ltd. Proposes Final Cash Dividend for the Year 2023Zhejiang Runtu Co., Ltd. proposed final cash dividend of CNY 1.50000000 per ten shares (tax included) for the year 2023.
お知らせ • May 01Zhejiang Runtu Co., Ltd., Annual General Meeting, May 24, 2024Zhejiang Runtu Co., Ltd., Annual General Meeting, May 24, 2024, at 14:00 China Standard Time. Location: Building 1, No. 1009, Shimin Avenue, Shangyu District, Shaoxing, Zhejiang China
Reported Earnings • Apr 30First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: CN¥1.25b (down 6.9% from 1Q 2023). Net income: CN¥1.31m (down 86% from 1Q 2023). Profit margin: 0.1% (down from 0.7% in 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
お知らせ • Mar 30Zhejiang Runtu Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024Zhejiang Runtu Co., Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024
Valuation Update With 7 Day Price Move • Feb 12Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥5.90, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 43% over the past three years.
お知らせ • Dec 30Zhejiang Runtu Co., Ltd. to Report Fiscal Year 2023 Results on Apr 30, 2024Zhejiang Runtu Co., Ltd. announced that they will report fiscal year 2023 results on Apr 30, 2024
Reported Earnings • Nov 01Third quarter 2023 earnings released: CN¥0.035 loss per share (vs CN¥0.046 profit in 3Q 2022)Third quarter 2023 results: CN¥0.035 loss per share (down from CN¥0.046 profit in 3Q 2022). Revenue: CN¥1.30b (down 10% from 3Q 2022). Net loss: CN¥41.6m (down 182% from profit in 3Q 2022). Revenue is forecast to grow 7.9% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
お知らせ • Sep 30Zhejiang Runtu Co., Ltd. to Report Q3, 2023 Results on Oct 31, 2023Zhejiang Runtu Co., Ltd. announced that they will report Q3, 2023 results on Oct 31, 2023
New Risk • Sep 13New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 45% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 111% Paying a dividend despite having no free cash flows. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.3% net profit margin).
Reported Earnings • Aug 31Second quarter 2023 earnings released: EPS: CN¥0.10 (vs CN¥0.25 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.10 (down from CN¥0.25 in 2Q 2022). Revenue: CN¥1.57b (down 14% from 2Q 2022). Net income: CN¥134.5m (down 53% from 2Q 2022). Profit margin: 8.6% (down from 16% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 2.3% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
お知らせ • Jun 14Zhejiang Runtu Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 20 June 2023Zhejiang Runtu Co., Ltd. announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 2.50000000 for the year 2022, payable on 20 June 2023. Record date is 19 June 2023. Ex-date is 20 June 2023.
お知らせ • Jun 01Zhejiang Runtu Co., Ltd. Approves Dividend for 2022Zhejiang Runtu Co., Ltd. announced at the AGM held on May 26, 2023 that the company approved Cash dividend/10 shares (tax included) of CNY2.50000000 for 2022.
お知らせ • May 06+ 1 more updateZhejiang Runtu Co., Ltd., Annual General Meeting, May 26, 2023Zhejiang Runtu Co., Ltd., Annual General Meeting, May 26, 2023, at 14:00 China Standard Time. Agenda: To consider 2022 work report of the board of directors; to consider 2022 work report of the supervisory committee; to consider 2022 annual accounts; to consider 2022 annual report and its summary; to consider 2022 profit distribution plan; to consider Confirmation of 2022 remuneration for directors and supervisors; to consider Reappointment of 2023 audit firm; to consider Provision of guarantee quota for subsidiaries and controlled sub-subsidiaries; and to consider other business matters.
Reported Earnings • Apr 08Full year 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.74 in FY 2021)Full year 2022 results: EPS: CN¥0.57 (down from CN¥0.74 in FY 2021). Revenue: CN¥6.30b (up 13% from FY 2021). Net income: CN¥645.2m (down 23% from FY 2021). Profit margin: 10% (down from 15% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 6 non-independent directors. Non-Independent Director Heng Ru was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 31Third quarter 2022 earnings released: EPS: CN¥0.046 (vs CN¥0.24 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.046 (down from CN¥0.24 in 3Q 2021). Revenue: CN¥1.45b (down 3.3% from 3Q 2021). Net income: CN¥50.5m (down 81% from 3Q 2021). Profit margin: 3.5% (down from 18% in 3Q 2021). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
Reported Earnings • Sep 02Second quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.21 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.25 (up from CN¥0.21 in 2Q 2021). Revenue: CN¥1.84b (up 37% from 2Q 2021). Net income: CN¥288.6m (up 29% from 2Q 2021). Profit margin: 16% (down from 17% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 4.0%, compared to a 33% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
Reported Earnings • May 02First quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.15 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.19 (up from CN¥0.15 in 1Q 2021). Revenue: CN¥1.58b (up 12% from 1Q 2021). Net income: CN¥211.1m (up 20% from 1Q 2021). Profit margin: 13% (in line with 1Q 2021). Over the next year, revenue is forecast to grow 18%, compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has fallen by 21% per year whereas the company’s share price has fallen by 18% per year.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 6 non-independent directors. Non-Independent Director Heng Ru was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Apr 01Full year 2021 earnings released: EPS: CN¥0.76 (vs CN¥0.69 in FY 2020)Full year 2021 results: EPS: CN¥0.76 (up from CN¥0.69 in FY 2020). Revenue: CN¥5.60b (up 7.0% from FY 2020). Net income: CN¥863.5m (up 9.6% from FY 2020). Profit margin: 15% (in line with FY 2020). Over the next year, revenue is forecast to grow 19%, compared to a 48% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has fallen by 21% per year whereas the company’s share price has fallen by 20% per year.
Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.24 (vs CN¥0.16 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥1.50b (up 7.7% from 3Q 2020). Net income: CN¥268.0m (up 48% from 3Q 2020). Profit margin: 18% (up from 13% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
Reported Earnings • Aug 30Second quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.13 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.34b (up 19% from 2Q 2020). Net income: CN¥224.2m (up 55% from 2Q 2020). Profit margin: 17% (up from 13% in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.
Reported Earnings • Apr 30Full year 2020 earnings released: EPS CN¥0.69 (vs CN¥1.19 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥5.23b (down 20% from FY 2019). Net income: CN¥788.2m (down 43% from FY 2019). Profit margin: 15% (down from 21% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 12% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Mar 12Full year 2020 earnings released: EPS CN¥0.68 (vs CN¥1.19 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥5.22b (down 20% from FY 2019). Net income: CN¥785.3m (down 43% from FY 2019). Profit margin: 15% (down from 21% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 12% per year, which means it is performing significantly worse than earnings.
Analyst Estimate Surprise Post Earnings • Mar 12Revenue misses expectationsRevenue missed analyst estimates by 9.6%. Over the next year, revenue is forecast to grow 35%, compared to a 52% growth forecast for the Chemicals industry in China.
Is New 90 Day High Low • Feb 02New 90-day high: CN¥10.98The company is up 18% from its price of CN¥9.29 on 05 November 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥17.48 per share.
Is New 90 Day High Low • Nov 23New 90-day high: CN¥10.38The company is up 5.0% from its price of CN¥9.87 on 25 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥16.48 per share.
Reported Earnings • Nov 01Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥849.2m, down 38% from the prior year. Total revenue was CN¥5.06b over the last 12 months, down 22% from the prior year.
Is New 90 Day High Low • Oct 31New 90-day low: CN¥8.95The company is down 6.0% from its price of CN¥9.56 on 31 July 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥14.96 per share.